Double stranded RNA activated EIF2 α kinase (EIF2AK2; PKR) is associated with Alzheimer's disease

Neurobiology of Aging

Volumn 29, Issue 8, 2008, Pages 1160-1166

  Bullido, María J ^a   Martínez García, Ana ^a   Tenorio, Raquel ^a   Sastre, Isabel ^a   Muñoz, David G ^b   Frank, Ana ^c   Valdivieso, Fernando ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Alzheimer; EIF2AK2; Genetic association; Onset age; PKR

Indexed keywords

APOLIPOPROTEIN E4; DOUBLE STRANDED RNA; PROTEIN KINASE R;

5' UNTRANSLATED REGION; ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVATION; EXON; FEMALE; GENOTYPE; HERPES SIMPLEX VIRUS 1; HOMOZYGOSITY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RNA SPLICING; RNA TRANSLATION; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS CELL INTERACTION;

AGED; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; EIF-2 KINASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; RNA, DOUBLE-STRANDED; SENSITIVITY AND SPECIFICITY; SPAIN;

EID: 44949254079     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2007.02.023     Document Type: Article

References (28)

1. Anon., 1997. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging 18 (4 Suppl.), S1-S2.
2. Bauer D., and Tampe R. Herpes viral proteins blocking the transporter associated with antigen processing TAP-from genes to function and structure. Curr. Top. Microbiol. Immunol. 269 (2002) 87-99
3. Bertram L., and Tanzi R.E. The genetic epidemiology of neurodegenerative disease. J. Clin. Invest. 115 6 (2005) 1449-1457
4. Bullido M.J., Artiga M.J., Recuero M., Sastre I., Garcia M.A., Aldudo J., Lendon C., Han S.W., Morris J.C., Frank A., Vazquez J., Goate A., and Valdivieso F. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat. Genet. 18 1 (1998) 69-71
5. Bullido M.J., Martinez-Garcia A., Artiga M.J., Aldudo J., Sastre I., Gil P., Coria F., Munoz D.G., Hachinski V., Frank A., and Valdivieso F. A TAP2 genotype associated with Alzheimer's disease in APOE4 carriers. Neurobiol. Aging 28 4 (2007) 519-523
6. Burgos J.S., Ramirez C., Sastre I., Bullido M.J., and Valdivieso F. Involvement of apolipoprotein E in the hematogenous route of herpes simplex virus type 1 to the central nervous system. J. Virol. 76 23 (2002) 12394-12398
7. Burgos J.S., Ramirez C., Sastre I., Bullido M.J., and Valdivieso F. ApoE4 is more efficient than E3 in brain access by herpes simplex virus type 1. Neuroreport 14 14 (2003) 1825-1827
8. Cartegni L., Chew S.L., and Krainer A.R. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat. Rev. Genet. 3 4 (2002) 285-298
9. Cartegni L., Wang J., Zhu Z., Zhang M.Q., and Krainer A.R. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res. 31 13 (2003) 3568-3571
10. Conde L., Vaquerizas J.M., Santoyo J., Al-Shahrour F., Ruiz-Llorente S., Robledo M., and Dopazo J. PupaSNP Finder: a web tool for finding SNPs with putative effect at transcriptional level. Nucleic Acids Res. 32 Web Server issue (2004) W242-W248
11. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., and Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 5123 (1993) 921-923
12. Chang R.C., Wong A.K., Ng H.K., and Hugon J. Phosphorylation of eukaryotic initiation factor-2alpha (eIF2alpha) is associated with neuronal degeneration in Alzheimer's disease. Neuroreport 13 18 (2002) 2429-2432
13. Fratiglioni L., De Ronchi D., and Aguero-Torres H. Worldwide prevalence and incidence of dementia. Drugs Aging 15 5 (1999) 365-375
14. Garcia M.A., Gil J., Ventoso I., Guerra S., Domingo E., Rivas C., and Esteban M. Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol. Mol. Biol. Rev. 70 4 (2006) 1032-1060
15. He B. Viruses, endoplasmic reticulum stress, and interferon responses. Cell Death Differ. 13 3 (2006) 393-403
16. Itzhaki R.F., Lin W.R., Shang D., Wilcock G.K., Faragher B., and Jamieson G.A. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 349 9047 (1997) 241-244
17. Itzhaki R.F., and Wozniak M.A. Herpes simplex virus type 1, apolipoprotein E, and cholesterol: a dangerous liaison in Alzheimer's disease and other disorders. Prog. Lipid Res. 45 1 (2006) 73-90
18. Knapp S., Yee L.J., Frodsham A.J., Hennig B.J., Hellier S., Zhang L., Wright M., Chiaramonte M., Graves M., Thomas H.C., Hill A.V., and Thursz M.R. Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. Genes Immun. 4 6 (2003) 411-419
19. Lambert J.C., Goumidi L., Vrieze F.W., Frigard B., Harris J.M., Cummings A., Coates J., Pasquier F., Cottel D., Gaillac M., St. Clair D., Mann D.M., Hardy J., Lendon C.L., Amouyel P., and Chartier-Harlin M.C. The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease. Hum. Mol. Genet. 9 15 (2000) 2275-2280
20. Li S., Peters G.A., Ding K., Zhang X., Qin J., and Sen G.C. Molecular basis for PKR activation by PACT or dsRNA. Proc. Natl. Acad. Sci. U.S.A. 103 26 (2006) 10005-10010
21. McCluskey J., Rossjohn J., and Purcell A.W. TAP genes and immunity. Curr. Opin. Immunol. 16 5 (2004) 651-659
22. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 7 (1984) 939-944
23. Mohr I. Neutralizing innate host defenses to control viral translation in HSV-1 infected cells. Int. Rev. Immunol. 23 1-2 (2004) 199-220
24. Onuki R., Bando Y., Suyama E., Katayama T., Kawasaki H., Baba T., Tohyama M., and Taira K. An RNA-dependent protein kinase is involved in tunicamycin-induced apoptosis and Alzheimer's disease. EMBO J. 23 4 (2004) 959-968
25. Paschen W., and Mengesdorf T. Endoplasmic reticulum stress response and neurodegeneration. Cell Calcium 38 3-4 (2005) 409-415
26. Peel A.L. PKR activation in neurodegenerative disease. J. Neuropathol. Exp. Neurol. 63 2 (2004) 97-105
27. Peel A.L., and Bredesen D.E. Activation of the cell stress kinase PKR in Alzheimer's disease and human amyloid precursor protein transgenic mice. Neurobiol. Dis. 14 1 (2003) 52-62
28. Wilson H.S., and Skodol A. Special report: DSM-IV: overview and examination of major changes. Arch. Psychiatr. Nurs. 8 6 (1994) 340-347